title: The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.
authors.affiliation: Department of Medical Oncology, St Bartholomew Hospital, London, UK.
authors.forename: P
authors.initials: P
authors.lastname: Thompson
authors.forename: P
authors.initials: P
authors.lastname: Wilson
authors.forename: R
authors.initials: R
authors.lastname: Osborne
authors.forename: M
authors.initials: M
authors.lastname: Slevin
authors.forename: F
authors.initials: F
authors.lastname: Wiltshaw
authors.forename: P
authors.initials: P
authors.lastname: Blake
authors.forename: P
authors.initials: P
authors.lastname: Harper
authors.forename: R
authors.initials: R
authors.lastname: Coleman
authors.forename: C
authors.initials: C
authors.lastname: Williams
authors.forename: J
authors.initials: J
authors.lastname: Sweetenham
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003534:Cyproterone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017373:Cyproterone Acetate; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D017373:Cyproterone Acetate; D003534:Cyproterone